Aull & Monroe Investment Management Corp Eli Lilly & CO Transaction History

Aull & Monroe Investment Management Corp

$213 Million
Q3 2024

A detailed history of Aull & Monroe Investment Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 10,192 shares of LLY stock, worth $7.79 Million. This represents 4.25% of its overall portfolio holdings.

Number of Shares

10,192

Previous 10,192 -0.0%

Holding current value

$7.79 Million

Previous $9.23 Million 2.15%

% of portfolio

4.25%

Previous 4.56%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $137,725 - $172,717	-190 Reduced 1.83%	10,192 $9.23 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $236,880 - $316,912	-400 Reduced 3.71%	10,382 $8.08 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $79,303 - $93,488	-151 Reduced 1.38%	10,782 $6.29 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $65,205 - $89,895	-150 Reduced 1.35%	10,933 $5.87 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $3,507 - $4,689	-10 Reduced 0.09%	11,083 $5.2 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $232,802 - $271,261	-724 Reduced 6.13%	11,093 $4.06 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $74,120 - $84,467	-250 Reduced 2.07%	11,817 $3.82 Million
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $47,218 - $58,598	-210 Reduced 1.71%	12,067 $3.33 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $10,415 - $12,817	-47 Reduced 0.38%	12,277 $2.84 Million
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $54,165 - $70,062	-300 Reduced 2.38%	12,324 $2.83 Million
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 1.56%	12,624 $2.36 Million
Q4 2020 Feb 02, 2021	SELL	$130.46 - $172.63 $21,786 - $28,829	-167 Reduced 1.29%	12,824 $2.17 Million
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $227,275 - $273,523	-1,666 Reduced 11.37%	12,991 $2.13 Million
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $5,539 - $6,466	-50 Reduced 0.34%	14,657 $1.62 Million
Q1 2019 Apr 18, 2019	SELL	$111.31 - $131.02 $134,239 - $158,010	-1,206 Reduced 7.58%	14,707 $1.91 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $112,254 - $125,758	-1,060 Reduced 6.25%	15,913 $1.84 Million
Q3 2018 Oct 31, 2018	SELL	$85.86 - $107.31 $21,465 - $26,827	-250 Reduced 1.45%	16,973 $1.82 Million
Q2 2018 Jul 24, 2018	BUY	$75.7 - $86.88 $7,570 - $8,688	100 Added 0.58%	17,223 $1.47 Million
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $40,970 - $43,945	-500 Reduced 2.84%	17,123 $1.45 Million
Q3 2017 Oct 26, 2017	SELL	$77.07 - $85.54 $23,120 - $25,662	-300 Reduced 1.67%	17,623 $1.51 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,923	17,923 $1.48 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.

Account

Aull & Monroe Investment Management Corp Eli Lilly & CO Transaction History